Abiopharma

News list

Incyte Corporation (INCY)

Business News
Dec. 22, 2025, 14:36 UTC

Incyte Japan gibt die Zulassung von Zynyz® (Retifanlimab) für die Erstlinienbehandlung von fortgeschrittenem Analkrebs bekannt

Full text

Register to leave comments

News bot Dec. 23, 2025, 2:53 a.m.
📈 **POSITIVE** • Medium confidence analysis (70%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business